Shopping Cart 0
Cart Subtotal
AED 0

Global Hereditary Angioedema Therapeutic Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 17910

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 26864

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 35819

Details

Description

Scope of the Report:

The global Hereditary Angioedema Therapeutic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hereditary Angioedema Therapeutic.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Hereditary Angioedema Therapeutic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hereditary Angioedema Therapeutic market by product type and applications/end industries.

Market Segment by Companies, this report covers

BioCryst Pharma

KalVista Pharma

CSL Limited

Ionis Pharma

Adverum Biotechnologies

Pharming Group

Attune Pharma

Shire

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Intravenous

Subcutaneous

Oral

Market Segment by Applications, can be divided into

Hospitals

Clinics

Others

READ MORE

Table Of Content

Scope

Table of Contents

1 Hereditary Angioedema Therapeutic Market Overview

1.1 Product Overview and Scope of Hereditary Angioedema Therapeutic

1.2 Classification of Hereditary Angioedema Therapeutic by Types

1.2.1 Global Hereditary Angioedema Therapeutic Revenue Comparison by Types (2019-2024)

1.2.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Types in 2018

1.2.3 Intravenous

1.2.4 Subcutaneous

1.2.5 Oral

1.3 Global Hereditary Angioedema Therapeutic Market by Application

1.3.1 Global Hereditary Angioedema Therapeutic Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Hereditary Angioedema Therapeutic Market by Regions

1.4.1 Global Hereditary Angioedema Therapeutic Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)

1.5 Global Market Size of Hereditary Angioedema Therapeutic (2014-2024)

2 Company Profiles

2.1 BioCryst Pharma

2.1.1 Business Overview

2.1.2 Hereditary Angioedema Therapeutic Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

2.2 KalVista Pharma

2.2.1 Business Overview

2.2.2 Hereditary Angioedema Therapeutic Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 KalVista Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

2.3 CSL Limited

2.3.1 Business Overview

2.3.2 Hereditary Angioedema Therapeutic Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 CSL Limited Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

2.4 Ionis Pharma

2.4.1 Business Overview

2.4.2 Hereditary Angioedema Therapeutic Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Ionis Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

2.5 Adverum Biotechnologies

2.5.1 Business Overview

2.5.2 Hereditary Angioedema Therapeutic Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

2.6 Pharming Group

2.6.1 Business Overview

2.6.2 Hereditary Angioedema Therapeutic Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Pharming Group Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

2.7 Attune Pharma

2.7.1 Business Overview

2.7.2 Hereditary Angioedema Therapeutic Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Attune Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

2.8 Shire

2.8.1 Business Overview

2.8.2 Hereditary Angioedema Therapeutic Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Shire Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

3 Global Hereditary Angioedema Therapeutic Market Competition, by Players

3.1 Global Hereditary Angioedema Therapeutic Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Hereditary Angioedema Therapeutic Players Market Share

3.2.2 Top 10 Hereditary Angioedema Therapeutic Players Market Share

3.3 Market Competition Trend

4 Global Hereditary Angioedema Therapeutic Market Size by Regions

4.1 Global Hereditary Angioedema Therapeutic Revenue and Market Share by Regions

4.2 North America Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

4.3 Europe Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

4.5 South America Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

5 North America Hereditary Angioedema Therapeutic Revenue by Countries

5.1 North America Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)

5.2 USA Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

5.3 Canada Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

5.4 Mexico Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

6 Europe Hereditary Angioedema Therapeutic Revenue by Countries

6.1 Europe Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)

6.2 Germany Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

6.3 UK Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

6.4 France Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

6.5 Russia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

6.6 Italy Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Countries

7.1 Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)

7.2 China Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

7.3 Japan Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

7.4 Korea Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

7.5 India Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

8 South America Hereditary Angioedema Therapeutic Revenue by Countries

8.1 South America Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)

8.2 Brazil Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

8.3 Argentina Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

8.4 Colombia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Hereditary Angioedema Therapeutic by Countries

9.1 Middle East and Africa Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)

9.2 Saudi Arabia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

9.3 UAE Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

9.4 Egypt Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

9.5 Nigeria Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

9.6 South Africa Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

10 Global Hereditary Angioedema Therapeutic Market Segment by Type

10.1 Global Hereditary Angioedema Therapeutic Revenue and Market Share by Type (2014-2019)

10.2 Global Hereditary Angioedema Therapeutic Market Forecast by Type (2019-2024)

10.3 Intravenous Revenue Growth Rate (2014-2024)

10.4 Subcutaneous Revenue Growth Rate (2014-2024)

10.5 Oral Revenue Growth Rate (2014-2024)

11 Global Hereditary Angioedema Therapeutic Market Segment by Application

11.1 Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2014-2019)

11.2 Hereditary Angioedema Therapeutic Market Forecast by Application (2019-2024)

11.3 Hospitals Revenue Growth (2014-2019)

11.4 Clinics Revenue Growth (2014-2019)

11.5 Others Revenue Growth (2014-2019)

12 Global Hereditary Angioedema Therapeutic Market Size Forecast (2019-2024)

12.1 Global Hereditary Angioedema Therapeutic Market Size Forecast (2019-2024)

12.2 Global Hereditary Angioedema Therapeutic Market Forecast by Regions (2019-2024)

12.3 North America Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

12.4 Europe Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

12.6 South America Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Figure

List of Tables and Figures

Figure Hereditary Angioedema Therapeutic Picture

Table Product Specifications of Hereditary Angioedema Therapeutic

Table Global Hereditary Angioedema Therapeutic and Revenue (Million USD) Market Split by Product Type

Figure Global Hereditary Angioedema Therapeutic Revenue Market Share by Types in 2018

Figure Intravenous Picture

Figure Subcutaneous Picture

Figure Oral Picture

Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) by Application (2014-2024)

Figure Hereditary Angioedema Therapeutic Revenue Market Share by Applications in 2018

Figure Hospitals Picture

Figure Clinics Picture

Figure Others Picture

Table Global Market Hereditary Angioedema Therapeutic Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)

Table BioCryst Pharma Basic Information, Manufacturing Base and Competitors

Table BioCryst Pharma Hereditary Angioedema Therapeutic Type and Applications

Table BioCryst Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table KalVista Pharma Basic Information, Manufacturing Base and Competitors

Table KalVista Pharma Hereditary Angioedema Therapeutic Type and Applications

Table KalVista Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table CSL Limited Basic Information, Manufacturing Base and Competitors

Table CSL Limited Hereditary Angioedema Therapeutic Type and Applications

Table CSL Limited Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table Ionis Pharma Basic Information, Manufacturing Base and Competitors

Table Ionis Pharma Hereditary Angioedema Therapeutic Type and Applications

Table Ionis Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table Adverum Biotechnologies Basic Information, Manufacturing Base and Competitors

Table Adverum Biotechnologies Hereditary Angioedema Therapeutic Type and Applications

Table Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table Pharming Group Basic Information, Manufacturing Base and Competitors

Table Pharming Group Hereditary Angioedema Therapeutic Type and Applications

Table Pharming Group Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table Attune Pharma Basic Information, Manufacturing Base and Competitors

Table Attune Pharma Hereditary Angioedema Therapeutic Type and Applications

Table Attune Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table Shire Basic Information, Manufacturing Base and Competitors

Table Shire Hereditary Angioedema Therapeutic Type and Applications

Table Shire Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) by Players (2014-2019)

Table Global Hereditary Angioedema Therapeutic Revenue Share by Players (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue Share by Players in 2017

Figure Global Hereditary Angioedema Therapeutic Revenue Share by Players in 2018

Figure Global Top 5 Players Hereditary Angioedema Therapeutic Revenue Market Share in 2018

Figure Global Top 10 Players Hereditary Angioedema Therapeutic Revenue Market Share in 2018

Figure Global Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) by Regions (2014-2019)

Table Global Hereditary Angioedema Therapeutic Revenue Market Share by Regions (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue Market Share by Regions (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue Market Share by Regions in 2018

Figure North America Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Europe Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure South America Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Table North America Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)

Table North America Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure North America Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure North America Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018

Figure USA Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Canada Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Mexico Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Table Europe Hereditary Angioedema Therapeutic Revenue (Million USD) by Countries (2014-2019)

Figure Europe Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure Europe Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018

Figure Germany Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure UK Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure France Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Russia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Italy Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Hereditary Angioedema Therapeutic Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018

Figure China Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Japan Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Korea Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure India Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Table South America Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)

Table South America Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure South America Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure South America Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018

Figure Brazil Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Argentina Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Colombia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Hereditary Angioedema Therapeutic Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018

Figure Saudi Arabia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure UAE Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Egypt Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Nigeria Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure South Africa Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) by Type (2014-2019)

Table Global Hereditary Angioedema Therapeutic Revenue Share by Type (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue Share by Type (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue Share by Type in 2018

Table Global Hereditary Angioedema Therapeutic Revenue Forecast by Type (2019-2024)

Figure Global Hereditary Angioedema Therapeutic Market Share Forecast by Type (2019-2024)

Figure Global Intravenous Revenue Growth Rate (2014-2019)

Figure Global Subcutaneous Revenue Growth Rate (2014-2019)

Figure Global Oral Revenue Growth Rate (2014-2019)

Table Global Hereditary Angioedema Therapeutic Revenue by Application (2014-2019)

Table Global Hereditary Angioedema Therapeutic Revenue Share by Application (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue Share by Application (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue Share by Application in 2018

Table Global Hereditary Angioedema Therapeutic Revenue Forecast by Application (2019-2024)

Figure Global Hereditary Angioedema Therapeutic Market Share Forecast by Application (2019-2024)

Figure Global Hospitals Revenue Growth Rate (2014-2019)

Figure Global Clinics Revenue Growth Rate (2014-2019)

Figure Global Others Revenue Growth Rate (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Hereditary Angioedema Therapeutic Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

Figure Europe Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

Figure South America Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

BioCryst Pharma

KalVista Pharma

CSL Limited

Ionis Pharma

Adverum Biotechnologies

Pharming Group

Attune Pharma

Shire

Company Profile

Company Profile Title

Description

Scope of the Report:

The global Hereditary Angioedema Therapeutic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hereditary Angioedema Therapeutic.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Hereditary Angioedema Therapeutic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hereditary Angioedema Therapeutic market by product type and applications/end industries.

Market Segment by Companies, this report covers

BioCryst Pharma

KalVista Pharma

CSL Limited

Ionis Pharma

Adverum Biotechnologies

Pharming Group

Attune Pharma

Shire

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Intravenous

Subcutaneous

Oral

Market Segment by Applications, can be divided into

Hospitals

Clinics

Others

READ MORE

Scope

Table of Contents

1 Hereditary Angioedema Therapeutic Market Overview

1.1 Product Overview and Scope of Hereditary Angioedema Therapeutic

1.2 Classification of Hereditary Angioedema Therapeutic by Types

1.2.1 Global Hereditary Angioedema Therapeutic Revenue Comparison by Types (2019-2024)

1.2.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Types in 2018

1.2.3 Intravenous

1.2.4 Subcutaneous

1.2.5 Oral

1.3 Global Hereditary Angioedema Therapeutic Market by Application

1.3.1 Global Hereditary Angioedema Therapeutic Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Hereditary Angioedema Therapeutic Market by Regions

1.4.1 Global Hereditary Angioedema Therapeutic Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)

1.5 Global Market Size of Hereditary Angioedema Therapeutic (2014-2024)

2 Company Profiles

2.1 BioCryst Pharma

2.1.1 Business Overview

2.1.2 Hereditary Angioedema Therapeutic Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

2.2 KalVista Pharma

2.2.1 Business Overview

2.2.2 Hereditary Angioedema Therapeutic Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 KalVista Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

2.3 CSL Limited

2.3.1 Business Overview

2.3.2 Hereditary Angioedema Therapeutic Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 CSL Limited Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

2.4 Ionis Pharma

2.4.1 Business Overview

2.4.2 Hereditary Angioedema Therapeutic Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Ionis Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

2.5 Adverum Biotechnologies

2.5.1 Business Overview

2.5.2 Hereditary Angioedema Therapeutic Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

2.6 Pharming Group

2.6.1 Business Overview

2.6.2 Hereditary Angioedema Therapeutic Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Pharming Group Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

2.7 Attune Pharma

2.7.1 Business Overview

2.7.2 Hereditary Angioedema Therapeutic Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Attune Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

2.8 Shire

2.8.1 Business Overview

2.8.2 Hereditary Angioedema Therapeutic Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Shire Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

3 Global Hereditary Angioedema Therapeutic Market Competition, by Players

3.1 Global Hereditary Angioedema Therapeutic Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Hereditary Angioedema Therapeutic Players Market Share

3.2.2 Top 10 Hereditary Angioedema Therapeutic Players Market Share

3.3 Market Competition Trend

4 Global Hereditary Angioedema Therapeutic Market Size by Regions

4.1 Global Hereditary Angioedema Therapeutic Revenue and Market Share by Regions

4.2 North America Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

4.3 Europe Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

4.5 South America Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

5 North America Hereditary Angioedema Therapeutic Revenue by Countries

5.1 North America Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)

5.2 USA Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

5.3 Canada Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

5.4 Mexico Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

6 Europe Hereditary Angioedema Therapeutic Revenue by Countries

6.1 Europe Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)

6.2 Germany Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

6.3 UK Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

6.4 France Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

6.5 Russia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

6.6 Italy Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Countries

7.1 Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)

7.2 China Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

7.3 Japan Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

7.4 Korea Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

7.5 India Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

8 South America Hereditary Angioedema Therapeutic Revenue by Countries

8.1 South America Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)

8.2 Brazil Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

8.3 Argentina Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

8.4 Colombia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Hereditary Angioedema Therapeutic by Countries

9.1 Middle East and Africa Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)

9.2 Saudi Arabia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

9.3 UAE Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

9.4 Egypt Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

9.5 Nigeria Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

9.6 South Africa Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

10 Global Hereditary Angioedema Therapeutic Market Segment by Type

10.1 Global Hereditary Angioedema Therapeutic Revenue and Market Share by Type (2014-2019)

10.2 Global Hereditary Angioedema Therapeutic Market Forecast by Type (2019-2024)

10.3 Intravenous Revenue Growth Rate (2014-2024)

10.4 Subcutaneous Revenue Growth Rate (2014-2024)

10.5 Oral Revenue Growth Rate (2014-2024)

11 Global Hereditary Angioedema Therapeutic Market Segment by Application

11.1 Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2014-2019)

11.2 Hereditary Angioedema Therapeutic Market Forecast by Application (2019-2024)

11.3 Hospitals Revenue Growth (2014-2019)

11.4 Clinics Revenue Growth (2014-2019)

11.5 Others Revenue Growth (2014-2019)

12 Global Hereditary Angioedema Therapeutic Market Size Forecast (2019-2024)

12.1 Global Hereditary Angioedema Therapeutic Market Size Forecast (2019-2024)

12.2 Global Hereditary Angioedema Therapeutic Market Forecast by Regions (2019-2024)

12.3 North America Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

12.4 Europe Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

12.6 South America Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Figure

List of Tables and Figures

Figure Hereditary Angioedema Therapeutic Picture

Table Product Specifications of Hereditary Angioedema Therapeutic

Table Global Hereditary Angioedema Therapeutic and Revenue (Million USD) Market Split by Product Type

Figure Global Hereditary Angioedema Therapeutic Revenue Market Share by Types in 2018

Figure Intravenous Picture

Figure Subcutaneous Picture

Figure Oral Picture

Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) by Application (2014-2024)

Figure Hereditary Angioedema Therapeutic Revenue Market Share by Applications in 2018

Figure Hospitals Picture

Figure Clinics Picture

Figure Others Picture

Table Global Market Hereditary Angioedema Therapeutic Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)

Table BioCryst Pharma Basic Information, Manufacturing Base and Competitors

Table BioCryst Pharma Hereditary Angioedema Therapeutic Type and Applications

Table BioCryst Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table KalVista Pharma Basic Information, Manufacturing Base and Competitors

Table KalVista Pharma Hereditary Angioedema Therapeutic Type and Applications

Table KalVista Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table CSL Limited Basic Information, Manufacturing Base and Competitors

Table CSL Limited Hereditary Angioedema Therapeutic Type and Applications

Table CSL Limited Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table Ionis Pharma Basic Information, Manufacturing Base and Competitors

Table Ionis Pharma Hereditary Angioedema Therapeutic Type and Applications

Table Ionis Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table Adverum Biotechnologies Basic Information, Manufacturing Base and Competitors

Table Adverum Biotechnologies Hereditary Angioedema Therapeutic Type and Applications

Table Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table Pharming Group Basic Information, Manufacturing Base and Competitors

Table Pharming Group Hereditary Angioedema Therapeutic Type and Applications

Table Pharming Group Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table Attune Pharma Basic Information, Manufacturing Base and Competitors

Table Attune Pharma Hereditary Angioedema Therapeutic Type and Applications

Table Attune Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table Shire Basic Information, Manufacturing Base and Competitors

Table Shire Hereditary Angioedema Therapeutic Type and Applications

Table Shire Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)

Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) by Players (2014-2019)

Table Global Hereditary Angioedema Therapeutic Revenue Share by Players (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue Share by Players in 2017

Figure Global Hereditary Angioedema Therapeutic Revenue Share by Players in 2018

Figure Global Top 5 Players Hereditary Angioedema Therapeutic Revenue Market Share in 2018

Figure Global Top 10 Players Hereditary Angioedema Therapeutic Revenue Market Share in 2018

Figure Global Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) by Regions (2014-2019)

Table Global Hereditary Angioedema Therapeutic Revenue Market Share by Regions (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue Market Share by Regions (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue Market Share by Regions in 2018

Figure North America Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Europe Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure South America Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Table North America Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)

Table North America Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure North America Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure North America Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018

Figure USA Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Canada Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Mexico Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Table Europe Hereditary Angioedema Therapeutic Revenue (Million USD) by Countries (2014-2019)

Figure Europe Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure Europe Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018

Figure Germany Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure UK Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure France Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Russia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Italy Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Hereditary Angioedema Therapeutic Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018

Figure China Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Japan Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Korea Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure India Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Table South America Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)

Table South America Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure South America Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure South America Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018

Figure Brazil Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Argentina Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Colombia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Hereditary Angioedema Therapeutic Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018

Figure Saudi Arabia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure UAE Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Egypt Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure Nigeria Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Figure South Africa Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)

Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) by Type (2014-2019)

Table Global Hereditary Angioedema Therapeutic Revenue Share by Type (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue Share by Type (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue Share by Type in 2018

Table Global Hereditary Angioedema Therapeutic Revenue Forecast by Type (2019-2024)

Figure Global Hereditary Angioedema Therapeutic Market Share Forecast by Type (2019-2024)

Figure Global Intravenous Revenue Growth Rate (2014-2019)

Figure Global Subcutaneous Revenue Growth Rate (2014-2019)

Figure Global Oral Revenue Growth Rate (2014-2019)

Table Global Hereditary Angioedema Therapeutic Revenue by Application (2014-2019)

Table Global Hereditary Angioedema Therapeutic Revenue Share by Application (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue Share by Application (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue Share by Application in 2018

Table Global Hereditary Angioedema Therapeutic Revenue Forecast by Application (2019-2024)

Figure Global Hereditary Angioedema Therapeutic Market Share Forecast by Application (2019-2024)

Figure Global Hospitals Revenue Growth Rate (2014-2019)

Figure Global Clinics Revenue Growth Rate (2014-2019)

Figure Global Others Revenue Growth Rate (2014-2019)

Figure Global Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Hereditary Angioedema Therapeutic Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

Figure Europe Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

Figure South America Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

BioCryst Pharma

KalVista Pharma

CSL Limited

Ionis Pharma

Adverum Biotechnologies

Pharming Group

Attune Pharma

Shire